Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
6 hedge funds and large institutions have $736K invested in Counterpath Corp in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less capital invested
Capital invested by funds: $891K → $736K (-$155K)
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$727K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$811K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$35K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$512 |
CPAH Hedge Fund Activity: Q2 2018 in Review
6 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q2 2018, worth a combined $736K — down 17% from $891K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPAH and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $727K. The largest seller was Fidelity Investments, exiting entirely with an estimated $811K sold.
- 6 institutional investors held Counterpath Corp (CPAH) as of Q2 2018, down from 8 in Q1 2018.
- Funds reported $736K of Counterpath Corp stock for Q2 2018, down 17% quarter-over-quarter.
- 1 fund opened new Counterpath Corp positions in Q2 2018 and 3 closed out, a net change of -2 holders.
- The largest Counterpath Corp buyer in Q2 2018 was Fidelity International, an estimated $727K added.
- The largest Counterpath Corp seller in Q2 2018 was Fidelity Investments, an estimated $811K sold.
Based on aggregated 13F filings for Q2 2018.